Hainan Puli Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") announces the following regarding the trading of its stock and convertible bonds during the delisting adjustment period:
300630SZSE
Third Risk Warning Announcement on the Company's Stock and Convertible Bonds Entering Delisting Adjustment Period Trading
✨ AI Summary
This announcement informs investors that the company's stock and convertible bonds will enter a delisting adjustment period starting April 28, 2025, with the last trading day expected on May 21, 2025. During this period, trading will be limited, and the company will not engage in major asset restructuring. Investors are advised to manage their positions and be aware of risks associated with the delisting.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.